6BQ1

Human PI4KIIIa lipid kinase complex


Experimental Data Snapshot

  • Method: ELECTRON MICROSCOPY
  • Resolution: 3.60 Å
  • Aggregation State: PARTICLE 
  • Reconstruction Method: SINGLE PARTICLE 

wwPDB Validation   3D Report Full Report


This is version 1.4 of the entry. See complete history


Literature

Architecture of the human PI4KIII alpha lipid kinase complex.

Lees, J.A.Zhang, Y.Oh, M.S.Schauder, C.M.Yu, X.Baskin, J.M.Dobbs, K.Notarangelo, L.D.De Camilli, P.Walz, T.Reinisch, K.M.

(2017) Proc Natl Acad Sci U S A 114: 13720-13725

  • DOI: 10.1073/pnas.1718471115
  • Primary Citation of Related Structures:  
    6BQ1

  • PubMed Abstract: 
  • Plasma membrane (PM) phosphoinositides play essential roles in cell physiology, serving as both markers of membrane identity and signaling molecules central to the cell's interaction with its environment. The first step in PM phosphoinositide synthesis is the conversion of phosphatidylinositol (PI) to PI4P, the precursor of PI(4,5)P 2 and PI(3,4,5)P 3 This conversion is catalyzed by the PI4KIIIα complex, comprising a lipid kinase, PI4KIIIα, and two regulatory subunits, TTC7 and FAM126 ...

    Plasma membrane (PM) phosphoinositides play essential roles in cell physiology, serving as both markers of membrane identity and signaling molecules central to the cell's interaction with its environment. The first step in PM phosphoinositide synthesis is the conversion of phosphatidylinositol (PI) to PI4P, the precursor of PI(4,5)P 2 and PI(3,4,5)P 3 This conversion is catalyzed by the PI4KIIIα complex, comprising a lipid kinase, PI4KIIIα, and two regulatory subunits, TTC7 and FAM126. We here report the structure of this complex at 3.6-Å resolution, determined by cryo-electron microscopy. The proteins form an obligate ∼700-kDa superassembly with a broad surface suitable for membrane interaction, toward which the kinase active sites are oriented. The structural complexity of the assembly highlights PI4P synthesis as a major regulatory junction in PM phosphoinositide homeostasis. Our studies provide a framework for further exploring the mechanisms underlying PM phosphoinositide regulation.


    Organizational Affiliation

    Department of Cell Biology, Yale University School of Medicine, New Haven, CT 06520; Pietro.decamilli@yale.edu twalz@mail.rockefeller.edu Karin.Reinisch@yale.edu.



Macromolecules
Find similar proteins by:  (by identity cutoff)  |  Structure
Entity ID: 1
MoleculeChainsSequence LengthOrganismDetailsImage
Phosphatidylinositol 4-kinase III alpha (PI4KA)A1647Homo sapiensMutation(s): 0 
Gene Names: PI4KAPIK4PIK4CA
EC: 2.7.1.67
UniProt & NIH Common Fund Data Resources
Find proteins for P42356 (Homo sapiens)
Explore P42356 
Go to UniProtKB:  P42356
PHAROS:  P42356
Protein Feature View
Expand
  • Reference Sequence
Find similar proteins by:  (by identity cutoff)  |  Structure
Entity ID: 2
MoleculeChainsSequence LengthOrganismDetailsImage
Tetratricopeptide repeat protein 7BB, E [auth F]863Homo sapiensMutation(s): 0 
Gene Names: TTC7BTTC7L1
UniProt & NIH Common Fund Data Resources
Find proteins for Q86TV6 (Homo sapiens)
Explore Q86TV6 
Go to UniProtKB:  Q86TV6
PHAROS:  Q86TV6
Protein Feature View
Expand
  • Reference Sequence
Find similar proteins by:  (by identity cutoff)  |  Structure
Entity ID: 3
MoleculeChainsSequence LengthOrganismDetailsImage
Protein FAM126AC, F [auth G]292Homo sapiensMutation(s): 0 
Gene Names: FAM126ADRCTNNB1A
UniProt & NIH Common Fund Data Resources
Find proteins for Q9BYI3 (Homo sapiens)
Explore Q9BYI3 
Go to UniProtKB:  Q9BYI3
PHAROS:  Q9BYI3
Protein Feature View
Expand
  • Reference Sequence
Find similar proteins by:  (by identity cutoff)  |  Structure
Entity ID: 4
MoleculeChainsSequence LengthOrganismDetailsImage
Phosphatidylinositol 4-kinase III alpha (PI4KA)D [auth E]1648Homo sapiensMutation(s): 0 
Gene Names: PI4KAPIK4PIK4CA
EC: 2.7.1.67
UniProt & NIH Common Fund Data Resources
Find proteins for P42356 (Homo sapiens)
Explore P42356 
Go to UniProtKB:  P42356
PHAROS:  P42356
Protein Feature View
Expand
  • Reference Sequence
Small Molecules
Ligands 1 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
E4S
Query on E4S

Download Ideal Coordinates CCD File 
G [auth A], H [auth E]5-{2-amino-1-[4-(morpholin-4-yl)phenyl]-1H-benzimidazol-6-yl}-N-(2-fluorophenyl)-2-methoxypyridine-3-sulfonamide
C29 H27 F N6 O4 S
AJOGHKUZDLYXKS-UHFFFAOYSA-N
 Ligand Interaction
Experimental Data & Validation

Experimental Data

  • Method: ELECTRON MICROSCOPY
  • Resolution: 3.60 Å
  • Aggregation State: PARTICLE 
  • Reconstruction Method: SINGLE PARTICLE 

Structure Validation

View Full Validation Report



Entry History & Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)United StatesGM114068

Revision History  (Full details and data files)

  • Version 1.0: 2017-12-13
    Type: Initial release
  • Version 1.1: 2017-12-27
    Changes: Database references
  • Version 1.2: 2018-01-03
    Changes: Database references
  • Version 1.3: 2018-01-17
    Changes: Author supporting evidence
  • Version 1.4: 2019-12-18
    Changes: Author supporting evidence, Other